ArticleRSC medicinal chemistry2025

Design, synthesis and evaluation of acetylcholine-antitumor lipid hybrids led to identification of a potential anticancer agent disrupting the CDK4/6-Rb pathway in lung cancer.

Ahmed H E Hassan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.